zopiclone has been researched along with Brain Vascular Disorders in 1 studies
zopiclone: S(+)-enantiomer of racemic zopiclone; azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; was term of zopiclone 2004-2007
zopiclone : A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rudenko, AE | 1 |
| Korzhenevskiĭ, LV | 1 |
| Bashkirova, LM | 1 |
1 trial available for zopiclone and Brain Vascular Disorders
| Article | Year |
|---|---|
[A new approach to the treatment of sleep disorders in patients with cerebrovascular diseases].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Azabicyclo Compounds; Cerebrovascular Disorder | 2003 |